Boston Trust Walden’s Synopsys SNPS Stock Holding History
Bought
Maintained
Sold
Other funds holding SNPS
Boston Trust Walden's SNPS Position: Q3 2026 in Review
Boston Trust Walden reduced its Synopsys (SNPS) stake by 2.4% in Q3 2026, selling an estimated $6.93K and leaving 698 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #362.
Boston Trust Walden first reported a position in SNPS in Q1 2021 and has held it in 23 quarters since. The position peaked at $12.3M in Q4 2021. 731 funds tracked by Wall St. Rank hold SNPS as of Q3 2026.
- Boston Trust Walden held 698 shares of Synopsys worth $304K as of Q3 2026.
- Boston Trust Walden sold 17 Synopsys shares in Q3 2026, an estimated $6.93K.
- Synopsys made up ﹤0.01% of Boston Trust Walden's portfolio in Q3 2026, its #362 holding.
- Boston Trust Walden first reported a position in Synopsys in Q1 2021 and has held it in 23 quarters since.
- Boston Trust Walden's Synopsys position peaked at $12.3M in Q4 2021.
- 731 funds tracked by Wall St. Rank held Synopsys as of Q3 2026.
Based on Boston Trust Walden's 13F filing for Q3 2026, filed 30 Oct 2026.